RecruitingNot ApplicableNCT05425524

Leptospirosis Care Bundle Study

Leptospirosis Care Bundle Study: A Randomized Controlled Trial


Sponsor

Chulalongkorn University

Enrollment

300 participants

Start Date

Oct 1, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

So in management of Leptospirosis patients There really is no another approach to treatment. The importance of the problem was acknowledged by the researchers. As a result, this study was performed in order to The Leptospirosis Care Bundle has been used, and has been proved that its use can reduce the risk of acute renal failure.


Eligibility

Min Age: 18 Years

Inclusion Criteria10

  • age > 18 years
  • Suspicious Leptospirosis including body temperature > 38 celcius, Severe myalgia, and exposure to reservoir hospital of flood water.
  • Calf muscle tenderness
  • Conjunctival suffusion
  • Anuria or oliguria and/or proteinuria
  • Jaundice
  • Hemorrhagic manifestations (pulmonary and intestine)
  • Meningeal irritation
  • Nausea, vomiting, abdominal pain, diarrhea.
  • Admitted in hospital

Exclusion Criteria2

  • other infectious disease
  • pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECare Bundle

Treatment step by step we have 5 steps STEP 1: Leptospirosis suspected case STEP 2: Investigations STEP 3: Antibiotics within 1 hour after Hemocultures were taken STEP 4: Intravenous Fluid STEP 5: Stage-Base Management of AKI (KDIGO)


Locations(1)

Chulalongkorn university

Bangkok, Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05425524


Related Trials